ArticleAdvances in experimental medicine and biology2026
Investigation of Anxiety, Stress, Depression, and Quality of Life of Pregnant Women with Gestational Diabetes Mellitus (GDM).
Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus (GDM) is a pregnancy complication that, according to the World Health Organization, is showing an increasing prevalence trend, mirroring the continuing upward trend of diabetes mellitus (DM) in the general population. The present study was based on the questions of the Depression, Anxiety, and Stress Scale DASS-21 and the World Health Organization Quality of Life Brief WHOQOL-BREF scales (translated into Greek). One hundred five pregnant women aged 21-44 participated in the study. The participants reported good mental health (low levels of stress, anxiety, and depression) with moderate levels of nervousness impacting them. Their social life was at a good level, they were satisfied with the environment they lived in, as well as their daily life; however, their physical health was at a moderate level. Also, the trimester of pregnancy appeared to play an important role in the onset of nervousness and depression in pregnant women with GDM as well as in their quality of life during pregnancy, with pregnant women in the first trimester reporting a lower quality of life than pregnant women in other trimesters. In contrast, women in the second gestational trimester reported the lowest depression rates. There was also an association between age and the prevalence of depression, with younger and older women experiencing depression at a higher frequency. Collectively, the psychological impact of GDM as well as its impact on the quality of life of pregnant women requires further investigation.
Indexed as
Identifiers
41479081What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.